Showing 99 of 99on this page. Filters & sort apply to loaded results; URL updates for sharing.99 of 99 on this page
Logo de Can Fite Biopharma au format PNG transparent
Can Fite Biopharma (CANF) - Market capitalization
Can Fite Biopharma ADR Aktie (A3D4G4 | US13471N3008) • onvista
Can - Fite Investor Presentation – Fall 2013 Pnina Fishman, PhD CEO
미국동전주(135)-CAN FITE 바이오파머(ADR) CANF #암치료제 #이스라엘
Can-Fite BioPharma (CANF) Stock Soars Over 100% on Positive Pancreatic ...
CANF Stock Forecast, Price & News (Can-Fite BioPharma)
Can-Fite BioPharma | Pharmaceutical | The Pharmaletter | The Pharmaletter
Following Pre-IND Guidance from FDA Can-Fite to Advance Piclidenoson ...
Buy Can-Fite BioPharma Ltd. Stock – CANF Stock Quote Today & Investment ...
Discover Can-Fite BioPharma Ltd.'s (NYSE American: CANF) latest ...
Can-Fite BioPharma reports Namodenoson's anti-cancer and anti ...
Quais são as cinco forças do Porter da Can-Fite Biopharma Ltd. (CANF ...
Can-Fite BioPharma: Advancing Oral Drugs for Oncology and Inflammation ...
ewopharma: Media
Can-Fite BioPharma Surges on $42.7-Million Deal With Ewopharma - TheStreet
Can-Fite Reports $4.9M H1 Loss, Advances Pancreatic Cancer Drug Trial ...
Can-Fite BioPharma - Piclidenoson (CF101)
CANF Forecast — Price Target — Prediction for 2026 — TradingView
Can-Fite BioPharma Secures $15 Million in Public Funding - Investors ...
Can-Fite to Participate in Two BioPharma Partnering Conferences ...
Exploring Can-Fite BioPharma Ltd. (CANF): Who s Buying and Why ...
Can-Fite BioPharma Ltd. Gains 26.92% | Stocktreats
Exploring Can-Fite BioPharma's Groundbreaking Drugs: Piclidenoson and ...
Inside Can-Fite BioPharma’s Clinical Pipeline with CEO Motti Farbstein ...
Can-Fite BioPharma Ltd. Stock — CANF Overview — Roic AI
A3AR激动剂先驱！Can-Fite银屑病新药计划提交FDA&EMA上市申请_摩熵医药
RedChip Companies TV Spot, 'Can-Fite BioPharma' - iSpot
Israel's Can-Fite BioPharma Rings The Opening Bell® at the NYSE - YouTube
Can-Fite BioPharma: Multi-Millionen-Deal in China
Can-Fite BioPharma shares surged 50% in pre-market on Brazilian patent win
Sign up today for our webinar with Can-Fite BioPharma Ltd. (NYSE ...
Can-Fite BioPharma Talks Clinical Development for Liver and ...
Interview with Can-Fite BioPharma (CANFY) CEO Dr. Pnina Fishman - YouTube
Can-Fite BioPharma - Technology Platform
Can-Fite BioPharma - Overview
Can-Fite Targets Rare Kidney Disease With New Phase 2 Lowe Syndrome ...
Can-Fite to Generate $685M in Projected Future Revenues
Can-Fite BioPharma (CANF) Stock Price & Overview
Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding
Can-Fite Biopharma CEO Dr. Pnina Fishman talks about the role of CF101 ...
Can-Fite Biopharma, Ltd. (NYSE American: CANF) Investor Webinar - Feb ...
CANF (Can-Fite Biopharma Ltd Sponsored) – Technical Charts and Market ...
Can-Fite (CANF) Up on Namodenoson Progress in Pancreatic Cancer
RedChip Companies TV Spot, 'Can-Fite BioPharma: Liver Cancer' - iSpot
CANF (Can-Fite Biopharma Ltd) – Technical Charts and Market Data ...
Can-Fite BioPharma - HOME
Can-Fite BioPharma Strengthens Position with New Canadian Patent
Can-Fite Surges on Pancreatic Cancer Treatment Approval
Can-Fite: Addressing Autoimmune-Inflammatory and Cancer Diseases - YouTube
Can-Fite CEO on oncology, inflammation, and clinical progress | RedChip ...
Can-Fite Granted U.S. Patent for Piclidenoson in the Treatment of ...
Can-Fite BioPharma Ltd. Stock Price: Quote, Forecast, Splits & News (CANF)
Can-Fite Reports New Data on Psoriasis Drug Offering Efficacy Similar ...
Can-Fite BioPharma Ltd. (CANF) – Stock Price, Charts & Fundamentals
RedChip Highlights Sixty Degrees Pharma(NASDAQ: SXTP) & Can-Fite ...
Can-Fite completes Phase 2a pancreatic cancer enrollment | CANF Stock News
Can-Fite Biopharma Stock Spiked 36.5% Higher on Patent Applications
Can-Fite BioPharma’s Promising Phase 2 Study on Namodenoson for ...
Can-Fite BioPharma - Cannabinoids
Can-Fite Biopharma Plunges 28.57%, What’s Fueling the Bloodletting in a ...
Can-Fite to start Phase II trial of pancreatic cancer therapy
Can-Fite BioPharma Ltd. (CANF): SWOT Analysis [Jan-2025 Updated] – DCF ...
RedChip Companies on LinkedIn: Can-Fite BioPharma (NYSE AMERICAN: CANF ...
Can-Fite BioPharma approves 1-for-3,000 reverse share split; shares down
Can-Fite BioPharma (CANF) Stock Soars 107% on Positive Pancreatic ...
Can-Fite Issued Japanese Patent for Treatment of Liver Regeneration ...
Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) Receives Positive FDA ...
New collaboration for Telethon Foundation and Can-Fite — TIGEM
Small Molecules for Big Clinical Needs – Can-Fite BioPharma | GCFF ...
CAN-FITE BIOPHARMA LTD.
Can-Fite BioPharma enrols first patient to study Covid-19 drug
U.S. FDA Agreed with Can-Fite’s Proposed Pivotal Phase III Trial Design ...
Can-Fite Initiates Compassionate Use Program for Namodenoson in the ...
Can-Fite BioPharma Ltd. (CANF) Stock | Drug Candidate Granted Orphan ...
Can-Fite BioPharma - Israeli Startup | Startup Nation Finder
FDA Clears Can-Fite to Commence Phase II COVID-19 Study | Business Wire
Can-Fite details Phase III trials, mid-stage pipeline and cash | CANF ...
Can-Fite to Present Drug Pipeline, $130M Deals at NobleCon21 | CANF ...
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on ...
Emerging Growth Confernce 60 - EmergingGrowth.com
